Janus Henderson Group’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Buy
594,712
+140,308
+31% +$4.54M 0.01% 625
2025
Q4
$15.7M Buy
+454,404
New +$16M 0.01% 652
2024
Q2
Sell
-257,080
Closed -$16.7M 2550
2024
Q1
$16.7M Buy
257,080
+80,748
+46% +$5.54M 0.01% 591
2023
Q4
$12.1M Buy
+176,332
New +$9.17M 0.01% 633

Other funds holding IMCR

Janus Henderson Group's IMCR Position: Q1 2026 in Review

Janus Henderson Group increased its Immunocore (IMCR) stake by 31% in Q1 2026, buying an estimated $4.54M and bringing the position to 594,712 shares worth $17.9M. The position accounts for 0.01% of the portfolio, ranked #625.

Janus Henderson Group first reported a position in IMCR in Q4 2023 and has held it in 4 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Janus Henderson Group held 594,712 shares of Immunocore worth $17.9M as of Q1 2026.
  • Janus Henderson Group bought 140,308 Immunocore shares in Q1 2026, an estimated $4.54M.
  • Immunocore made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #625 holding.
  • Janus Henderson Group first reported a position in Immunocore in Q4 2023 and has held it in 4 quarters since.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.